Actuate Therapeutics, Inc.
ACTU
$6.89
-$0.33-4.57%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | ||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 192.07% | -- | -- | -89.89% | |
| Total Receivables | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | |
| Prepaid Expenses | 1,434.69% | -- | -- | -- | |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | |
| Total Current Assets | 207.38% | -- | -- | -- | |
|
|
|||||
| Total Current Assets | 207.38% | -- | -- | -- | |
| Net Property, Plant & Equipment | -- | -- | -- | -- | |
| Long-term Investments | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | |
| Total Other Intangibles | -- | -- | -- | -- | |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | |
| Total Other Assets | -- | -- | -- | -- | |
| Total Assets | 211.07% | -- | -- | -- | |
|
|
|||||
| Total Accounts Payable | -43.85% | -- | -- | -- | |
| Total Accrued Expenses | 96.68% | -- | -- | -- | |
| Short-term Debt | -- | -- | -- | -- | |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | |
| Finance Division Debt Current | -- | -- | -- | -- | |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | |
| Total Other Current Liabilities | -- | -- | -- | -- | |
| Total Current Liabilities | 27.19% | -- | -- | -- | |
|
|
|||||
| Total Current Liabilities | 27.19% | -- | -- | -- | |
| Long-Term Debt | -- | -- | -- | -- | |
| Short-term Debt | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | |
| Finance Division Debt Non Current | -- | -- | -- | -- | |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | |
| Total Other Liabilities | -23.03% | -- | -- | -- | |
| Total Liabilities | 23.59% | -- | -- | -- | |
|
|
|||||
| Common Stock & APIC | 2,322.90% | -- | -- | -- | |
| Retained Earnings | -25.96% | -- | -- | -- | |
| Treasury Stock & Other | -- | -- | -- | -- | |
| Total Common Equity | 100.10% | -- | -- | -43.12% | |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | |
| Preferred Stock Convertible | -- | -- | -- | -- | |
| Preferred Stock, Others | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | 4.67% | |
|
|
|||||
| Total Common Equity | 100.10% | -- | -- | -43.12% | |
| Total Preferred Equity | -- | -- | -- | 4.67% | |
| Total Minority Interest | -- | -- | -- | -- | |
| Total Equity | 102.34% | -- | -- | -180.37% | |
|
|
|||||
